Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | 1.23% | 89.07 | 1.3% | $885.86m | |
| AMGN | Amgen Inc. | 0.09% | 191.49 | 1.2% | $554.58m | |
| GILD | Gilead Sciences, Inc. | 0.72% | 65.49 | 0.9% | $453.28m | |
| ONCE | Spark Therapeutics, Inc. | -0.25% | 113.67 | 11.2% | $443.24m | |
| BIIB | Biogen Inc. | -0.58% | 323.76 | 1.3% | $352.26m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.15% | 406.99 | 2.6% | $278.79m | |
| ILMN | Illumina, Inc. | 1.61% | 310.70 | 3.5% | $273.06m | |
| BPTH | Bio-Path Holdings, Inc. | -9.32% | 25.20 | 190.1% | $257.65m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -3.05% | 181.76 | 1.9% | $239.61m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.28% | 126.47 | 15.4% | $205.98m | |
| EXAS | Exact Sciences Corporation | -0.85% | 91.15 | 25.3% | $189.71m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.43% | 132.94 | 2.0% | $178.02m | |
| A | Agilent Technologies, Inc. | 0.28% | 81.20 | 1.6% | $151.29m | |
| IONS | Ionis Pharmaceuticals, Inc. | 0.11% | 79.61 | 8.3% | $101.25m | |
| BMRN | BioMarin Pharmaceutical Inc. | -2.06% | 91.44 | 4.3% | $95.59m |
Company Profile
Selecta Biosciences, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. it produces the Synthetic Vaccine Particles (SVP) platform for immune tolerance and immune stimulation. The firm proprietary pipeline includes SVP-enabled enzyme, oncology and gene therapies. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian in 2007 and is headquartered in Watertown, MA.